Health Care & Life Sciences » Biotechnology | Cynata Therapeutics Ltd.

Cynata Therapeutics Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,094.60
4,703.70
4,879.20
10,349.80
12,206.00
Total Accounts Receivable
6.00
44.20
54.70
87.70
52.70
Other Current Assets
3.60
3.60
3.60
3.60
341.10
Total Current Assets
5,104.10
4,751.50
4,937.40
10,441.00
12,599.80
Intangible Assets
4,821.80
4,373.90
4,093.10
3,813.20
3,533.20
Total Assets
9,925.90
9,125.40
9,030.50
14,254.20
16,133.00
ST Debt & Current Portion LT Debt
-
32.70
-
-
-
Accounts Payable
34.90
152.60
133.50
94.90
299.10
Other Current Liabilities
36.40
190.10
313.90
294.70
447.10
Total Current Liabilities
71.30
375.40
447.40
389.60
746.10
Total Liabilities
71.30
375.40
447.40
389.60
746.10
Common Equity (Total)
9,854.60
8,750.00
8,583.10
13,864.60
15,386.90
Total Shareholders' Equity
9,854.60
8,750.00
8,583.10
13,864.60
15,386.90
Total Equity
9,854.60
8,750.00
8,583.10
13,864.60
15,386.90
Liabilities & Shareholders' Equity
9,925.90
9,125.40
9,030.50
14,254.20
16,133.00

About Cynata Therapeutics

View Profile
Address
62 Lygon Street
Carlton Victoria (VIC) 3053
Australia
Employees -
Website http://www.cynata.com
Updated 07/08/2019
Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. It focuses on therapeutic stem cell platform technology. The company was founded on March 12, 2003 and is headquartered in Carlton, Australia.